Loading people...
Robert Stein is Founder and Chief Executive Officer at Astor Management, based in New York City, NY, USA.
Robert Stein co-founded Astor Management and has also been involved with Samsara BioCapital.
Robert Stein is a Venture Partner at Samsara BioCapital, an advisor to Agenus, and Executive Vice President of Research and Development at MiMedx Group. Over a career of thirty-five years in the pharmaceutical and biotechnology sectors, he has directed the discovery and commercialization of eight marketed drugs, including Eliquis, Promacta, and Sustiva. Prior to his current positions, Stein held senior leadership roles across several major pharmaceutical firms, serving as President of Roche Palo Alto, Head of Pharmacology for Merck, and President and Chief Scientific Officer of Incyte Pharmaceuticals. He also served as Chief Executive Officer of KineMed and cofounded Flame Biosciences, an enterprise focused on therapies for cancer and inflammatory conditions. Equipped with an MD and a PhD, he currently focuses on advising early-stage biotech companies and guiding global research and development initiatives.
